The effects of serotonin modulation on medial prefrontal connectivity strength and stability:A pharmacological fMRI study with citalopram by Arnone, D. et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1016/j.pnpbp.2018.01.021
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Arnone, D., Wise, T., Walker, C., Cowen, P. J., Howes, O., & Selvaraj, S. (2018). The effects of serotonin
modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with
citalopram. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 84(Part A), 152-159.
https://doi.org/10.1016/j.pnpbp.2018.01.021
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 05. Apr. 2019
Accepted Manuscript
The effects of serotonin modulation on medial prefrontal
connectivity strength and stability: A pharmacological fMRI
study with citalopram
D. Arnone, T. Wise, C. Walker, P.J. Cowen, O. Howes, S. Selvaraj
PII: S0278-5846(17)30282-8
DOI: doi:10.1016/j.pnpbp.2018.01.021
Reference: PNP 9332
To appear in: Progress in Neuropsychopharmacology & Biological Psychiatry
Received date: 9 April 2017
Revised date: 12 January 2018
Accepted date: 30 January 2018
Please cite this article as: D. Arnone, T. Wise, C. Walker, P.J. Cowen, O. Howes, S.
Selvaraj , The effects of serotonin modulation on medial prefrontal connectivity strength
and stability: A pharmacological fMRI study with citalopram. The address for the
corresponding author was captured as affiliation for all authors. Please check if
appropriate. Pnp(2017), doi:10.1016/j.pnpbp.2018.01.021
This is a PDF file of an unedited manuscript that has been accepted for publication. As
a service to our customers we are providing this early version of the manuscript. The
manuscript will undergo copyediting, typesetting, and review of the resulting proof before
it is published in its final form. Please note that during the production process errors may
be discovered which could affect the content, and all legal disclaimers that apply to the
journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 1 
The effects of serotonin modulation on medial prefrontal connectivity strength and stability: a 
pharmacological fMRI study with citalopram  
Arnone D MRCPsych1*, Wise T PhD1, 2*, Walker C PhD3, Cowen PJ FRCPsych4, Howes O 
MRCPsych5, 6✚, Selvaraj S MRCPsych3✚  
*/
✚
: These authors contributed equally 
1Centre for Affective Disorders, Department of Psychological Medicine, Institute of 
Psychiatry, Psychology & Neuroscience, King’s College London, London, UK  
2Max Planck UCL Centre for Computational Psychiatry and Ageing Research, University 
College London, London, UK 
3UT Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral 
Sciences, UT Houston Medical School, Houston, TX, USA 
 
4Neurosciences Building, Department of Psychiatry, University of Oxford, Warneford 
Hospital, Oxford, UK 
 
5Medical Research Council Clinical Sciences Centre (CSC) and Institute of Clinical Sciences (ICS), 
Imperial College London, UK 
 
6Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK 
 
Correspondence to:  
Danilo Arnone, Centre for Affective Disorders, Department of Psychological Medicine, 
Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK ; 
danilo.arnone@kcl.ac.uk 
and 
Sudhakar Selvaraj, UT Center of Excellence on Mood Disorders, Department of Psychiatry 
and Behavioral Sciences, UT Houston Medical School, Houston, TX, USA; 
Sudhakar.Selvaraj@uth.tmc.edu 
 
Abstract: 201 
Words: 4534 
Figures: 3 
Tables: 2 + 1 supplementary 
References: 46 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 2 
Abstract 
Background: Static and dynamic functional connectivity are being increasingly used to 
measure the effects of disease and a range of different interventions on brain networks.  
Whilst preliminary evidence suggests that static connectivity can be modulated by chronic 
antidepressants administration in healthy individuals and in major depression, much less is 
known about the acute effects of antidepressants especially on dynamic functional 
connectivity changes. Here we examine acute effects of antidepressants on dynamic 
functional connectivity within the default mode network. The default mode network is a well 
described network with many functions in which the role of serotonin is not clear. 
Methods: In this work we measured acute pharmacological effects of an infusion of the 
selective serotonin reuptake inhibitor (SSRI) citalopram 10 mg in a sample of thirteen healthy 
volunteers randomised to receive on two occasions the active compound or placebo in a cross 
over dosing.  
Results: Acute citalopram administration relative to placebo increased static connectivity 
between the medial prefrontal cortex and right dorsolateral prefrontal cortex and posterior 
cingulate cortex. The SSRI also induced a reduction in variability of connectivity with the 
medial prefrontal cortex in the precuneus and posterior cingulate cortex.  
Discussion: The measured changes are compatible with modified serotonin cortical 
availability. 
Keywords: Serotonin; MRI; functional MRI; Citalopram; SSRI. 
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1. Introduction 
The medial prefrontal cortex, a pivotal component of the default mode network (DMN) 
involved in decision-making, attention, and self-referential processes (Perkins et al., 2015), 
shares extensive connectivity with cortical and limbic regions involved in affective 
modulation.  
 
Connectivity strength between these regions and other overlapping areas including the ‘dorsal 
nexus’ has been shown to be increased in major depression (Sheline et al., 2010) and reduced 
in affected individuals by antidepressants such as selective serotonin reuptake inhibitors 
(SSRIs) (Wang et al., 2015), indicating that it plays a pivotal role in affective dysregulation 
and that serotonergic dysfunction might underpin aberrant function in this network. A similar 
effect has been shown in healthy individuals with chronic antidepressant administration, an 
effect primarily directed towards subcortical limbic nodes such as the hippocampus and 
amygdala (McCabe and Mishor, 2011)(McCabe et al., 2011)(Wang et al., 2015) functionally 
related to medial prefrontal regions. 
 
Recent interest has focused on investigating the variability of functional connectivity to 
complement a more conventional measure of the strength of the functional interdependence 
within brain networks. Whilst a measure of connectivity strength assumes that the neural 
signal within the network is constant, the proposed measure of functional variability explores 
the variability of the signal within the very same network which reflects the dynamic nature 
of intra and inter-region neural processes (Hutchison and Morton, 2016)(Calhoun et al., 
2014). Understanding connectivity variations over time might provide further information on 
the biological mechanisms underlying affective disorders in conjunction with measures of 
connectivity strength.  
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For example, a recent experiment in major depression explored differences in the variability 
of functional connectivity originating from the medial prefrontal cortex vs. healthy 
individuals and indicated an increased variability in functional connectivity with dorsolateral 
prefrontal cortex and insula, possibly an indication of a self-directed ruminative cognitive 
style, and decreased variability with the parahippocampal gyrus (Kaiser et al., 2016). This 
indicates that abnormalities in connectivity dynamics may be an important pathological 
feature of the disorder. Despite their effectiveness and widespread use as first line treatment 
for affective disorders, the mechanism of action of selective serotonin reuptake inhibitors 
(SSRIs) is not fully elucidated (Cleare et al., 2015). Studying the effects of SSRIs in healthy 
volunteers provides an opportunity for improving our knowledge and to perfect future 
pharmacological interventions. To our knowledge, there is no study to date investigating 
pharmacological effects on both static and dynamic functional connectivity following acute 
administration of an SSRI in healthy individuals.  
In this study we set out to evaluate the acute pharmacological effects of serotonergic 
modulation using an SSRI on strength and stability of resting state functional connectivity in 
the medial prefrontal cortex in healthy individuals. We chose to focus on the default mode 
network, as it is a well-described network with many functions relevant to depression and in 
which the role of serotonin is not clear. As such, our method used independent component 
analysis (ICA) to identify this network, and further analyses were performed within the 
identified default mode network component. In view of the wide distribution in the brain of 
serotonergic receptors (Klaassens et al., 2015) and the known interaction between the DMN 
and the central executive and salience networks relevant to depressive disorders (Manoliu et 
al., 2013) we also performed exploratory analyses in these two resting state networks.   
A number of lines of evidence indicate that the immediate effect of acute SSRI administration 
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is to reduce serotonin neuronal firing and hence postsynaptic serotonin cortical availability in 
animals (Gartside et al., 1995) and humans (Selvaraj et al., 2012), likely mediated by the 
dorsal raphe nuclei via inhibitory 5HT1A autoreceptors (Selvaraj et al., 2012). In view of this 
we hypothesized that acute SSRI administration would result in heightened connectivity 
strength as shown in untreated major depression in the medial prefrontal cortex. We also 
postulated that the SSRI infusion would result in altered stability in the medial prefrontal 
cortex depending on the regions involved in line with findings in major depression. 
 
2. Methods 
2.1 Sample 
Inclusion criteria were male and female healthy subjects aged between 35 and 65 years 
(Selvaraj et al., 2012) (Selvaraj et al., 2017). Thirteen healthy male participants agreed to take 
part and were screened using DSM-IV (SCID) criteria to exclude any significant current or 
past psychiatric history prior to participating in this study.  Exclusion criteria included any 
significant psychopathology, any relevant medical history or contraindication to MRI 
scanning, present and past (previous 3 months) use of psychotropic medication, current 
significant illicit substance/alcohol misuse. Drug use was excluded with a urine drug screen 
prior to each scan. Sinus rhythm and absence of any QT prolongation were confirmed 
electrocardiographically prior to study inclusion.  
The study involved two sessions separated by at least a one-week interval between them. 
Each session consisted of a 30 minutes intravenous infusion of either normal saline or 10 mg 
of citalopram followed by a functional MRI resting state scan. The scan took place 
approximately 15-30 minutes after the infusion when circulating citalopram was at its peak 
concentration (Selvaraj et al., 2012). Hence each participant received infusions with a single-
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blind (study subject), random order, cross-over design. Blood samples were collected in both 
experiments for citalopram levels prior to the infusion (t=0min) and before the MRI scan 
(t=45min). The Hamilton Depression Rating Scale 17 items (HAMD-17), the Beck 
Depression Inventory (BDI) and the State-Trait Anxiety Inventory were administered to 
investigate potential pharmacological emotional effects on the subjects and the Visual 
Analogue Scales (VAS) to ascertain subjective affective responses on emotions (including 
anxiety, sadness, happiness, anger, and irritability) across sessions. Potential side effects were 
systematically monitored. 
The National Research Ethics Service, West London Committee, approved the study and all 
the subjects consented to their participation. Participants were given a small compensation for 
taking part in the study. MRI scans were carried out at the Hammersmith Hospital in London, 
Institute of Clinical Studies, MRC Centre. 
 
2.2 Design 
2.2.1 Functional MRI Acquisition 
MRI was performed on a 3T scanner (3T Intera Philips Medical Systems (Best, The 
Netherlands) to acquire 32 T2*-weighted transverse echoplanar images (EPI) per volume 
with blood oxygenation level dependent (BOLD) contrast. EPIs were acquired with 1.95 
mm*1.95 mm voxel dimensions in-plane, repetition time=2s, echo time=30 ms, phase 
encoding direction=anterior-posterior, field of view=576 mm2, matrix size 112x112. These 
comprised 3.25 mm-thick axial slices with no between slice gap. A total of 192 EPI volumes 
were collected with slices acquired in an even-odd interleaved in a descending direction. 
Real-time reconstruction, z-shimming correction and a slice tilt of −30° to the anterior 
commissure–posterior commissure line were used to minimize orbitofrontal and temporal 
signal dropout as a result of magnetic field inhomogeneities due to air tissue susceptibility 
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differences in these regions (Weiskopf et al., 2006)(Weiskopf et al., 2007). A whole-brain 
3D-MPRAGE scan was acquired (TR=9.6 ms, TE=4.5 ms, flip angle=8°, slice thickness = 
1.2 mm, 0.94 mm × 0.94 mm in plane resolution, 150 slices) after EPI scans. 
2.2.2 Functional MRI Preprocessing 
Data were pre-processed with custom Nipype (http://nipy.org/nipype/) scripts, using tools 
from SPM12 (http://www.fil.ion.ucl.ac.uk/spm) and FSL 5.0.9 (http://fsl.fmrib.ox.ac.uk/) in 
addition to custom code. Data were first realigned to the first functional image before slice 
timing correction was performed. These images were then co-registered to the T1 scan and 
normalised to MNI space using the forward deformation fields generated from segmentation 
of the structural image. Time series from white matter and CSF regions, plus six motion 
parameters (three translation plus three rotation) were regressed from the data, before 
temporally filtered from 0.009 to 0.08hz. These images were finally demeaned, detrended, 
and smoothed with a 6mm FWHM kernel.  
2.2.3 Motion scrubbing 
Head motion is an important source of noise in resting state data, and can lead to spurious 
estimates of resting state connectivity (Power et al., 2012). To minimise the influence of head 
motion on our results, we performed motion scrubbing. Time points demonstrating excessive 
motion were identified using FSL motion outliers tools based on RMS intensity differences 
between volumes and DVARS (Power et al., 2012), with default settings. In traditional 
connectivity analyses these time points are typically removed from the time series, however 
this would affect the length of the time series and hence dynamic functional connectivity 
estimates. We therefore interpolated the scrubbed time points using 3rd order b-spline 
interpolation. To further ensure that differences between drug conditions were not influenced 
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by motion, we compared motion parameters (total distance travelled, mean frame-wise 
displacement, and maximum frame-wise displacement) between drug and placebo conditions.  
2.2.4 Seed region of interest definition 
Default mode network regions were identified using group Canonical ICA (Varoquaux et al., 
2010) with 20 clusters. The default mode network component is illustrated in Figure 3, and 
peak coordinates are provided in Table 1. A 3D map of the component is available to 
download from ‘Figshare’ at the following address: 
https://figshare.com/articles/Citalopram_connectivity_DMN_component/4309439. A 
spherical region of interest with a diameter of 10mm was generated at the peak coordinates of 
the mPFC cluster identified as described above, and the mean time series was extracted from 
this region for further analysis. The entire default mode network component was used to 
provide regions of interest for subsequent voxelwise analyses. 
We also performed exploratory analyses in two further resting state networks (the central 
executive network and salience network) to examine whether the effects of citalopram 
extended beyond our hypothesised default mode regions. We used a similar process to 
identify seed regions and regions of interest, extracting signal from a 10mm sphere at the 
peak of a dorsolateral prefrontal cluster (MNI coordinates = 8, 30, 62) for the central 
executive network, and an anterior cingulate cortex cluster (0, -2, 56) for the salience 
network. These entire networks were then used for small volume correction when assessing 
effects of citalopram within these networks. 
2.2.5 Static functional connectivity analysis 
We also computed static connectivity using the Fisher Z-transformed Pearson correlation 
between the entire mPFC time series and the time series of all other voxels in the brain to 
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produce whole brain maps of connectivity with the mPFC seed. These maps were entered 
into a two-way ANOVA with drug condition and order of administration as factors, allowing 
both main effects of drug and order to be explored in addition to the drug X order interaction. 
To control for multiple comparisons, statistical maps were thresholded with a cluster-defining 
voxelwise threshold of .001 and a cluster-wise threshold of .05 FDR corrected using small 
volume correction within the DMN, central executive network, or salience network regions 
identified previously using ICA. 
2.2.6 Dynamic functional connectivity analysis 
Whole-brain sliding window analysis was performed using custom Python 
(https://www.python.org/) scripts. Pearson correlations between the mPFC time series and 
time series of all other voxels were calculated using a series of 40 second Gaussian windows 
with a standard deviation of 8 seconds, sliding by 1 TR. This window length was chosen to 
provide optimal sensitivity to fluctuations on connectivity strength (see Wise et al., 2017 for 
further discussion on the choice of window lengths and related preprocessing steps). The 
correlation values for each window were then transformed to Fisher’s Z-scores. Variability of 
these correlation values across the brain was measured using their standard deviation to 
create whole brain variability maps. Placebo and citalopram variability maps were compared 
using the same method as the static analyses. The dynamic functional connectivity analysis 
procedure is illustrated in Figure 1.  
 
3. Results 
3.1. Demographic details and mood ratings 
Thirteen male participants (mean age of 48 +/-9 years) completed the study with 30 days 
mean interval between visits. Average rating scales score and standard deviation (SD) were 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 10 
HAMD-17 = 0.82 (3.1), BDI = 1.46 (1.8), State Anxiety Inventory = 42.62 (3.4) and Trait 
Anxiety Inventory = 28.20 (6.7). There were no reported significant side effects following 
citalopram infusion and affective measures did not report significant differences between 
sessions on subjective VAS affective state measures (paired t tests, all Ps>0.1).  
3.2 Static and dynamic connectivity analyses 
When comparing citalopram with placebo, static connectivity with the medial prefrontal 
cortex was increased under citalopram in the bilateral dorsolateral prefrontal cortex and 
posterior cingulate cortex (Table 1 and Figure 2). This finding suggests that neural 
communication between the medial prefrontal cortex and these two regions is strengthened 
following acute citalopram infusion. Dynamic functional connectivity analysis demonstrated 
that in the citalopram vs. placebo comparison the variability of the connectivity between 
medial prefrontal cortex,  precuneus and posterior cingulate cortex was significantly reduced 
(Table 2, Figure 2 and Supplementary Table 1), indicating that connectivity within between 
these areas had become more stable.  
We found a main effect of drug administration order on static connectivity strength in the left 
angular gyrus and the left precuneus, and a significant drug X order effect in the middle 
temporal gyrus (Table 1). There were no effects of order or interactions with drug condition 
in the dynamic functional connectivity analysis. 
Analysis of motion parameters demonstrated no significant differences between drug and 
placebo conditions in total distance moved (t(11) = -0.70, p = .42), mean frame-wise 
displacement (t(11) = -0.54, p = .60), or maximum frame-wise displacement (t(11) = 0.73, p 
= .48). There were also no differences in the number of interpolated time points (t(11) = -
0.51, p = .62) suggesting that the measured differences were induced by the infusion of 
citalopram. 
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We also performed exploratory analyses of the effects of citalop ram on static and dynamic 
functional connectivity in the central executive network and salience network. However these 
analyses did not reveal any significant effects of citalopram or drug administration order, and 
did not show any effects of a drug X administration order interaction when looking at either 
dynamic or static connectivity. 
 
4. Discussion 
We set out to investigate the effect of the SSRI citalopram on static and dynamic resting state 
connectivity of the medial prefrontal cortex in a sample of healthy individuals. Acute 
citalopram administration increased static connectivity between the medial prefrontal cortex 
and right dorsolateral prefrontal cortex and posterior cingulate cortex relative to placebo. The 
SSRI also induced a reduction in variability of connectivity with the medial prefrontal cortex 
in the precuneus and posterior cingulate cortex. Together these findings indicate that 
citalopram has effects on both connectivity strength and stability. The medial prefrontal 
cortex is a central component of the DMN and shares connectivity with the ‘dorsal nexus’, 
posterior cingulate cortex, the dorsolateral prefrontal cortex and precuneus relevant in 
affective regulation (Sheline et al., 2010).  
Acutely, citalopram blocks the reuptake of serotonin leading to decreased cortical synaptic 
serotonin via initial inhibitory mechanisms based on raphe 5HT1A autoreceptor activation 
which is believed to dominate the initial phase of antidepressant treatment (Selvaraj et al., 
2012)(Nord et al., 2013)(Arnone et al., 2002). Studies in healthy participants indicate that a 
more prolonged period of treatment (7 days) with citalopram might actually decrease static 
connectivity between prefrontal cortex and limbic regions including the amygdala and 
hippocampus (McCabe and Mishor, 2011). This would seem in keeping with the belief that 
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chronic or sub-chronic SSRI administration leads to adaptive synaptic changes compatible 
with an optimal level of serotonergic synaptic availability. The acute SSRI challenge in this 
experiment resulted in increased static connectivity between the medial prefrontal cortex and 
right dorsolateral prefrontal cortex and posterior cingulate cortex relative to placebo 
complemented by a reduction in connectivity variability in the medial prefrontal cortex with 
precuneus and posterior cingulate cortex. These findings add to Schaefer and others’ work 
investigating the effect of a single oral dose of escitalopram on brain functional connectivity. 
The authors reported a general decrease in intrinsic connectivity at whole brain level in most 
cortical and sub-cortical areas with localised increases in cerebellum and thalamus although 
their methodology did not allow exploration of static and dynamic connectivity (Schaefer et 
al., 2014).  Our approach expands on their work and indicates a localised increase in static 
connectivity in the network comprising the medial prefrontal cortex, right dorsolateral 
prefrontal cortex and posterior cingulate cortex. This alteration in functional synchronisation 
might speculatively reflect functional ‘rigidity’ or an exaggerated state of over coupling in 
this network as postulated by Voytek and Knight to explain disruption in neural 
communication occurring in neuropsychiatric disorders (Voytek and Knight, 2015) and 
possibly reflecting a state of hyperconnectivity noted in similar regions in the depressed state 
(Sheline et al., 2010). There is no clear consensus with regard to the interpretation of 
functional dynamic changes in the context of a pharmacological challenge. The most striking 
element is that dynamic connectivity provides a window to capture neural communication 
compatible with fluctuations in level of consciousness, which in the context of this 
experiment might reflect synaptic changes associated with an increase in the level of 
serotonin. A reduction in connectivity variability in the identified network in line with 
variation associated by sleep, sedation, and pharmacological compounds capable of inducing 
anaesthesia (Deng et al., 2016) (Hutchison and Morton, 2016), suggests a decrease in 
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spontaneous ‘mind wandering’ and ‘self generated thoughts (Kucyi, 2017), potentially related 
to a ‘ruminative cognitive style’ linked with conditions such as major depression and anxiety 
disorders (Perkins et al., 2015). Interestingly we have recently demonstrated greater 
connectivity variability in unmedicated individuals with major depression vs. healthy controls 
in the network which includes the medial prefrontal cortex and the posterior cingulate cortex 
significantly correlating with measures of a ‘ruminative response style’ in the presence of 
more pronounced anxiety symptoms (Wise et al., 2017) suggesting the possibility that SSRIs 
might be able to modify brain responses in these disorders.  
Pharmacological manipulation of serotoninergic neurotransmission resulting in reduction of 
functional connectivity in the anterior and posterior cingulate cortices, hippocampal complex 
and lateral parietal regions in healthy volunteers has been demonstrated with the SSRIs 
escitalopram (van de Ven et al., 2013) and sertraline (Klaassens et al., 2015) and generic 
decreased in functional resting state connectivity within the DMN have been demonstrated 
with the serotonin and noradrenaline reuptake inhibitor duloxetine (van de Ven et al., 2013) 
and with psilocybin, a 5-HT2A/2C receptor agonist (Carhart-Harris et al., 2012). Studies 
inducing a reduction in 5-HT brain availability by administering a mixture of amino acids 
without the 5-HT precursor tryptophan (acute tryptophan depletion), have reported 
conflicting results.  Helmbold and others in a sample of women demonstrated enhanced 
resting state connectivity in the left inferior and middle frontal cortices (including the 
DLPFC), and reduced functional connectivity in the left precuneus (Helmbold et al., 2016). 
These findings are opposite to what we would expect based on our results following an acute 
reduction in 5-HT brain availability. Our data are more consistent with Kunisato and 
colleagues reporting a decrease in the middle orbitofrontal cortex and precuneus and an 
increase in the superior parietal lobule, paracentral lobule and precentral gyrus following 
tryptophan depletion (Kunisato et al., 2011). Discrepancies in the results can be explained by 
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study design and methodological differences including citalopram dosing and potential 
variations in the techniques used to obtain tryptophan depletion which could contribute to 
pharmacokinetics variations. Further studies which take into consideration these parameters 
appear necessary to ensure replication.  
The dorsolateral prefrontal cortex (DLPFC) is more commonly associated with the executive 
control network than the DMN. However the DLPFC is a large region composed of multiple 
sub-regions with varying patterns of anatomical and functional connectivity, and sub-regions 
of the DLPFC do often appear in network parcellations. For example the lateral areas of 
Brodmann area 8 appear in the default mode network component of the Yeo parcellations 
(Yeo et al., 2011), which represent standard templates for resting state networks derived from 
a large sample, and this region of the DLPFC was shown in some of the first studies of the 
default mode network (Fransson, 2005; Greicius et al., 2003). As such, the appearance of the 
DLPFC in our ICA component is expected. Additionally, the exact location of the default 
mode network will always vary from sample to sample due to individual anatomical and 
functional variability. This was in fact the reasoning behind our use of an ICA-derived 
default mode network template rather than an existing network template.  As a result, 
although the precise location of default mode clusters may differ from study to study, we can 
be confident that our DLPFC cluster represents the same component of the default mode 
network as the DLPFC cluster shown in many previous studies of the DMN. 
Notably, we found no effect of citalopram on either static or dynamic functional connectivity 
in the central executive network or salience network in exploratory analyses. Although this 
may suggest that citalopram affects functional connectivity primarily in the default mode 
network, it is important to interpret this result in the context of our relatively small sample 
size which may have limited our ability to detect weaker effects in these networks.  Another 
possibility is that acute citalopram administration affects the DMF because this is the major 
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active network during resting state, contrary to the central executive or salience networks 
which are not functionally active. The acute strengthening of the DMN resting state 
functional connectivity (by increasing functional connectivity and decreasing connectivity 
variability) between MPFC and PCC, does not preclude subsequent changes in central 
executive or salience networks which were not measured in the time frame of this study. 
Based on the results from this study and in un-medicated patients with major depression 
(Wise et al., 2017), SSRIs might act by stabilizing the DMN. 
The neural networks under investigation in this study, part of the DMN, are involved in a 
wide range of cognitive and behavioural functions and include neural circuits responsible for 
social behaviour, executive functions, motivation, vigilance, self-awareness and autonomic 
control. These functions are mediated by cortical and subcortical centres, including the limbic 
system and medial prefrontal cortex which show alterations in both structure and function in 
mood disorders (Wise et al., 2014)(Arnone et al., 2016)(Wise et al., 2016). Similarly to acute 
tryptophan depletion studies (Cowen and Browning, 2015), in the absence of significant 
perceived mood changes or ‘state effects’, the acute administration of an SSRI in healthy 
volunteers could induce detectable changes in the availability of serotonin at neural level.  
This study shows that changes in serotonergic tone can be measured at brain level as 
variation in strength and stability of functional connectivity within the DMN. According to 
conventional theories this might speculatively represent the neural equivalent of decreased 
cortical serotonin availability mediated by inhibitory 5HT1A autoreceptor agonism. It is 
however becoming evident that the molecular and cellular mechanisms, which constitute the 
theoretical basis for SSRI acute and chronic synaptic adaptation, are likely to be incomplete  
(Harmer et al., 2017). As an example 5HT1A-blocking agents do not accelerate clinical 
response (Scorza et al., 2012)(Harmer et al., 2017), and the onset of clinical effects have been 
shown to supervene sooner than previously believed (Taylor et al., 2006). Hence, other 
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mechanisms may also contribute to the observed neural effects and rapid adaptive process to 
explain the acute SSRI action shown in this work. These might include fast acting synaptic 
changes medicated by Ca2+ channels, activation of tropomyosin related kinase signalling 
pathways, changes in brain derived neurotrophic factor (Zetterström et al., 1999)(Schaefer et 
al., 2014) and in glutamatergic neurotransmission (Arnone et al., 2015).  
Further work is necessary to fully understand circuit level functioning at regional level 
responsible for the measured changes in connectivity strength and stability. This might be 
achieved by using complementary techniques such as electroencephalography (EEG) to 
investigate electric neuronal activity concomitant to BOLD signal changes  (Hutchison and 
Morton, 2016). Furthermore, it would be important to study temporal variability of functional 
connectivity in major depression in response to treatment and clinical improvement as 
dynamic changes measured in healthy volunteers may not reflect baseline functional 
connectivity variability in affected samples.  
Study limitations include current technical capabilities in capturing dynamic variability in 
functional connectivity, differences in bioavailability between participants for the compound 
of choice, and the relatively small sample size.  In relation to sample size 12 subjects is 
generally considered the minimum number for functional neuroimaging studies (Desmond 
and Glover, 2002) although the within-subjects design and the use of an experimental 
intervention are likely to increase the power to detect a meaningful signal. We did not detect 
any significant order or drug X order interactions on static connectivity. A drug X order 
interaction was detected in one of the connectivity stability significant clusters which 
although not necessarily relevant in view of the counter-balanced design, it actually increased 
the strength of our main effects (likely due to accounting for additional order-related variance 
in the model). Further studies are needed to compare functional connectivity strength and 
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variability and its relationship with serotonin function and major depression in men and 
women. 
There is also no clear consensus on what constitutes the optimal time window for dynamic 
functional connectivity analysis and data interpretation (Hutchison and Morton, 2016), and 
there is some debate over temporal filtering of the BOLD signal (Leonardi and Van De Ville, 
2015). The combination of a voxelwise cluster-defining threshold of <.001 and cluster-level 
threshold of <.05 FDR corrected used in this work, has been shown to provide an acceptable 
false-positive rate (Eklund et al., 2016)(Flandin and Friston, 2017). As a result, we believe 
that our current method (using cluster- level correction within the network masks) is the most 
appropriate way to control for multiple comparisons in our analyses. Different methods are 
however available including using peak- level correction. Using this approach within our large 
volumes would have been overly conservative and cluster-level correction provides a more 
powerful way to correct for multiple comparisons in this case. Peak- level correction allows 
inferences to be made about the specific location of activations, while this specificity is lost 
with cluster-level correction. Hence, we cannot make any strong claims beyond stating that 
the cluster as a whole shows an effect, as making more precise statements about the location 
of these effects would be inappropriate based on cluster-level thresholding. 
Additionally, the 6-½ minute resting state scan used here may not have been of sufficient 
duration to capture less rapid fluctuations in connectivity, and may limit the reliability of our 
connectivity estimates. However, it is not clear from the published literature what constitutes 
an optimal scan duration for dynamic functional connectivity analysis, and to what extent the 
scan duration used here limits our estimates of dynamic functional connectivity. Finally, there 
has been some debate in the literature regarding methods of hypothesis testing in dynamic 
functional connectivity research. This is typically with testing for the presence of dynamic 
functional connectivity and the need to set a null model where fluctuations in connectivity are 
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absent (Hindriks et al., 2016a)(Hindriks et al., 2016b). The issue of testing for effects of 
experimental interventions on connectivity dynamics has received little attention and future 
work should focus on optimising methods for detecting these effects. Finally, the clusters 
observed in the posterior cingulate cortex and angular gyrus in our dynamic connectivity 
analysis were small and by no means indicate that the entirety of these default mode regions 
exhibited different patterns of connectivity depending on drug administration order. 
Additionally, it is not clear from the current study why such an effect of order may be 
present.  
Nevertheless, this study shows for the first time that acute SSRI administration can affect 
both static and dynamic functional connectivity within relevant brain networks and although 
the use of acutely administered citalopram is of limited clinical relevance to longer-term 
citalopram administration or to later antidepressant efficacy, individual differences in the 
brain’s response to citalopram administration may be used as a useful tool for stratification. 
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Figure 1: Illustration of the dynamic functional connectivity analysis procedure. mPFC region of interest MNI 
coordinates: 14, 56, 2. mPFC: Medial prefrontal cortex, PCC: Posterior cingulate cortex, ICA: Independent 
component analysis. 
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Figure 2: Strength and stability of connectivity within the default mode network under placebo and citalopram 
conditions. The medial prefrontal cortex seed is represented in blue  on the 3D images. PCC: Posterior cingulate 
cortex, DLPFC: Dorsolateral prefrontal cortex. 
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Figure 3: Default mode network component derived using independent component analysis. 
 
 
Region 
Brodmann 
area 
Cluster extent 
(voxels) 
F 
FDR-
corrected p 
X Y Z 
Effect of drug condition        
Right dorsolateral prefrontal 
cortex 
8 18 48.06 0.020 28 12 54 
Posterior cingulate cortex 39 17 61.56 0.002 0 -24 26 
Left dorsolateral prefrontal 
cortex 
8 13 94.04 0.033 -22 22 52 
Effect of order        
No significant clusters         
Drug X order interaction        
No significant clusters         
Table 1 : Results of voxelwise analysis of connectivity strength between medial prefrontal cortex and other 
default mode network regions. X, Y, and Z values represent MNI coordinates. Clusters defined at a voxelwise 
threshold of .001 uncorrected with a cluster-level threshold of .05 FDR corrected. 
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Region 
Brodmann 
area 
Cluster extent 
(voxels) 
F 
FDR-
corrected p 
X Y Z Direction 
Effect of drug condition         
Precuneus 31 21 70.35 < .001 -2 -56 38 C > P 
Posterior cingulate 
cortex 
23 17 45.68 < .001 -2 -38 30 
C > P 
Effect of order         
Angular gyrus 39 20 66.25 0.001 -46 -72 30 PC > CP 
Precuneus 23 7 45.65 0.041 -4 -64 28 PC > CP 
Angular gyrus 39 9 35.24 0.032 -40 -56 24 PC > CP 
Drug X order interaction         
Middle temporal gyrus 21 7 36.95 0.044 48 -50 16 - 
Table 2: Results of voxelwise analysis of connectivity variability between medial p refrontal cortex and other 
default mode network regions. C: citalopram, P: placebo, PC: placebo first, citalopram second, CP: citalopram 
first, placebo second. X, Y, and Z values represent MNI coordinates. Clusters defined at a voxelwise threshold 
of .001 uncorrected with a cluster-level threshold of .05 FDR corrected. 
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Highlights 
 In this work we examine the acute effects of the selective serotonin reuptake inhibitor 
citalopram on dynamic functional connectivity in a sample of healthy volunteers 
within the default mode network, a well-described network with many functions.  
 Acute citalopram administration relative to placebo increased static connectivity 
between the medial prefrontal cortex and right dorsolateral prefrontal cortex and 
posterior cingulate cortex. The SSRI also induced a reduction in variability of 
connectivity with the medial prefrontal cortex in the precuneus and posterior cingulate 
cortex.  
 The measured changes are compatible with modified serotonin cortical availability. 
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